- Home
- CVRX vs MPAA Comparison
CVRX vs MPAA Comparison
Compare CVRX & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- MPAA
- Stock Information
- Founded
- CVRX 2000
- MPAA 1968
- Country
- CVRX United States
- MPAA United States
- Employees
- CVRX N/A
- MPAA N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- MPAA Auto Parts:O.E.M.
- Sector
- CVRX Health Care
- MPAA Consumer Discretionary
- Exchange
- CVRX Nasdaq
- MPAA Nasdaq
- Market Cap
- CVRX 174.4M
- MPAA 188.9M
- IPO Year
- CVRX 2021
- MPAA 1994
- Fundamental
- Price
- CVRX $5.89
- MPAA $9.76
- Analyst Decision
- CVRX Buy
- MPAA
- Analyst Count
- CVRX 7
- MPAA 0
- Target Price
- CVRX $14.50
- MPAA N/A
- AVG Volume (30 Days)
- CVRX 232.7K
- MPAA 196.3K
- Earning Date
- CVRX 07-28-2025
- MPAA 06-09-2025
- Dividend Yield
- CVRX N/A
- MPAA N/A
- EPS Growth
- CVRX N/A
- MPAA N/A
- EPS
- CVRX N/A
- MPAA N/A
- Revenue
- CVRX $52,870,000.00
- MPAA $757,354,000.00
- Revenue This Year
- CVRX $11.53
- MPAA $7.74
- Revenue Next Year
- CVRX $18.61
- MPAA N/A
- P/E Ratio
- CVRX N/A
- MPAA N/A
- Revenue Growth
- CVRX 25.62
- MPAA 5.53
- 52 Week Low
- CVRX $4.30
- MPAA $5.16
- 52 Week High
- CVRX $18.55
- MPAA $12.72
- Technical
- Relative Strength Index (RSI)
- CVRX 41.15
- MPAA 40.16
- Support Level
- CVRX $5.54
- MPAA $10.28
- Resistance Level
- CVRX $5.96
- MPAA $10.97
- Average True Range (ATR)
- CVRX 0.40
- MPAA 0.75
- MACD
- CVRX -0.03
- MPAA -0.22
- Stochastic Oscillator
- CVRX 21.99
- MPAA 6.33
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.